Yield10 Bioscience, Inc. stock is down -33.03% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 17.65% of the previous 17 November’s closed higher than October. 50% of analysts rate it a buy.
Yield10 Bioscience, Inc. engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG.